Global Neuroprotective Agents Market Size, Trends & Analysis - Forecasts To 2026 By Drug (Cholinesterase Inhibitors, Anti-inflammatory & Anti-apoptotic Agents, NMDA Receptor Antagonists, Neurotropic Factors, Mitochondrial Dysfunction Regulators, Free Radical Trappers, Anti-Excitotoxic Agents, Others), By Indication (Alzheimers Disease, Multiple Sclerosis, Parkinsons Disease, Huntingtons Disease, Neuropathies, Brain Injury, Others), By Region (North America, Europe, Asia Pacific, MEA, CSA), Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Global Neuroprotective Agents Market Size, Trends & Analysis - Forecasts To 2026 By Drug (Cholinesterase Inhibitors, Anti-inflammatory & Anti-apoptotic Agents, NMDA Receptor Antagonists, Neurotropic Factors, Mitochondrial Dysfunction Regulators, Free Radical Trappers, Anti-Excitotoxic Agents, Others), By Indication (Alzheimers Disease, Multiple Sclerosis, Parkinsons Disease, Huntingtons Disease, Neuropathies, Brain Injury, Others), By Region (North America, Europe, Asia Pacific, MEA, CSA), Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

  • Published Date: June 17 : 2020
  • Base Year for Estimate: 2019
  • Report Id:2090

Neuroprotective Agents Market Insights

The global neuroprotective agents market is estimated to witness a significant CAGR during the forecast period (2020-2026). Growing incidence and prevalence of neurodegenerative diseases along with rise in stroke and traumatic central nervous system injuries are some of the major factors expected to drive the market growth during the forecast period. Moreover, rising demand for the product for various purposes in hospitals, medical facilities, and nursing homes is one of the significant factors driving market growth. Neuroprotective agents have potential in reducing stroke damage. Neuroprotective agents in clinical pipelines include small-molecule drugs, therapeutic monoclonal antibodies, gene and cell therapies, and other agents. Neuroprotection or prevention of neuronal loss is a process that is mediated by various cellular pathways. The most common conditions associated with nervous system involvement are trauma, shock, stroke, sepsis, traumatic brain injury (TBI) and ruptured brain aneurys and their increasing prevalence is the major driver for the market growth. However, insufficient clinical research, and high costs in developing the product are some of the factors likely to hamper the market growth.

Neuroprotective Agents Market Size: By Drug

Based on drug, the market is segmented into cholinesterase inhibitors, anti-inflammatory & anti-apoptotic agents, NMDA receptor antagonists, neurotrophic factors, mitochondrial dysfunction regulators, free radical trappers, and anti-excitotoxic agents, among others. The cholinesterase inhibitors segment is expected to grow at a high CAGR during the forecast period. Cholinesterase Inhibitors are prescribed to individuals with dementia caused by Alzheimers disease. Furthermore, NMDA receptors are expected to hold the largest market share during the forecast period. NMDA receptors antagonists were the first class of therapeutic agents for acute stroke. They used modern principles of clinical trial design, developed from laboratory to testing in humans, and had early treatment.

Neuroprotective Agents Market Size: By Indication

Based on the indication, the market is segmented into Alzheimers disease, multiple sclerosis, Parkinsons disease, Huntingtons disease, neuropathies, and brain injury, among others. There has been an evolution of cotinine as neuroprotective agents and it improves information processing, attention, and memory-related task performance that have relevance to Alzheimers disease. Minocycline, creatine, and rasagiline are the most promising agents for neuroprotection in Parkinsons disease and all three are now in Phase III trials and market share shall increase in the forecast period due to new drug discovery and clinical trials.

Neuroprotective Agents Market

Neuroprotective Agents Market Size: By Region

Based on region, the market is segmented into North America, Europe, Asia-Pacific, CSA, and Middle East and Africa. North America is expected to hold the largest market share during the forecast period. According to the research conducted, approximately 60,000 U.S. population is diagnosed with Parkinsons disease every year. Growing demand for neuroprotective drugs and investment in research and development activities is expected to propel the market growth in the region. Asia-Pacific region is expected to grow at a high CAGR during the forecast period with increasing investment in drug discovery and emergence of key players, and growing preventive health care measures.

Neuroprotective Agents Market Share & Competitor Analysis

Some of the key players operating in the neuroprotective agents market include: Eisai Inc. Merck, Serono S.A., Novartis AG, GlaxoSmithKline Plc, Bayer Healthcare, Genervon Biopharmaceuticals, NeuroVive Pharmaceutical, Teva Pharmaceutical Industries Ltd., Ceregene, BHRPharma LLC, Allon therapeutics, Inc., Neuren Pharmaceuticals, and Bionure Inc., among others.

Please note: This is not an exhaustive list of companies profiled in the report.

  • In May 2020, GlaxoSmithKline Plc entered into partnership with Samsung Biologics to manufacture and supply GSKs innovative biopharmaceutical therapies worldwide
  • In May 2020, Bayer entered into collaboration with ArcherDX to develop next-generation sequencing (NGS)-based companion diagnostic (CDx) for precision oncology treatment Vitrakvi

Neuroprotective Agents Market: By Drug

  1. Introduction 
    1. Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     
  2. Cholinesterase Inhibitors   
    1. Cholinesterase Inhibitors: Neuroprotective Agents Market, 2020-2026 (USD Million)
  3. Anti-inflammatory & Anti-apoptotic Agents         
    1. Anti-inflammatory & Anti-apoptotic Agents: Neuroprotective Agents Market, 2020-2026 (USD Million)
  4. NMDA Receptor Antagonists         
    1. NMDA Receptor Antagonists: Neuroprotective Agents Market, 2020-2026 (USD Million)
  5. Neurotropic Factors
    1. Neurotropic Factors: Neuroprotective Agents Market, 2020-2026 (USD Million)
  6. Mitochondrial Dysfunction Regulators     
    1. Mitochondrial Dysfunction Regulators: Neuroprotective Agents Market, 2020-2026 (USD Million)
  7. Free Radical Trappers        
    1. Free Radical Trappers: Neuroprotective Agents Market, 2020-2026 (USD Million)
  8. Anti-excitotoxic Agents       
    1. Anti-excitotoxic Agents: Neuroprotective Agents Market, 2020-2026 (USD Million)
  9. Others           
    1. Others: Neuroprotective Agents Market, 2020-2026 (USD Million)

Neuroprotective Agents Market: By Indication

  1. Introduction
    1. Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)        
  2. Alzheimers Disease
    1. Alzheimers Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)
  3. Multiple Sclerosis    
    1. Multiple Sclerosis: Neuroprotective Agents Market, 2020-2026 (USD Million)
  4. Parkinsons Disease
    1. Parkinsons Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)
  5. Huntingtons Disease           
    1. Huntingtons Disease: Neuroprotective Agents Market, 2020-2026 (USD Million)
  6. Brain Injury  
    1. Brain Injury: Neuroprotective Agents Market, 2020-2026 (USD Million)
  7. Others           
    1. Others: Neuroprotective Agents Market, 2020-2026 (USD Million)

Neuroprotective Agents Market: By Region

  1. Introduction 
    1. Global Neuroprotective Agents Market, By Region, 2020-2026 (USD Million) 
  2. North America         
    1. By Drug          
      1. North America Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)      
    2. By Indication 
      1. North America Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)     
    3. By Country     
      1. U.S     
        1. By Drug          
          1. U.S Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. U.S Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 
      2. Canada          
        1. By Drug          
          1. Canada Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. Canada Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   
      3. Mexico           
        1. By Drug          
          1. Mexico Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. Mexico Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   
  3. Europe          
    1. By Drug          
      1. Europe Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    
    2. By Indication 
      1. Europe Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)      
    3. By Country     
      1. Germany        
        1. By Drug          
          1. Germany Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. Germany Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   
      2. UK      
        1. By Drug          
          1. UK Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. UK Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 
      3. France
        1. By Drug          
          1. France Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. France Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)               
      4. Italy    
        1. By Drug          
          1. Italy Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. Italy Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 
      5. Rest Of Europe         
        1. By Drug          
          1. Rest Of Europe Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     
        2. By Indication 
          1. Rest Of Europe Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)     
  4. Asia Pacific  
    1. By Drug          
      1. Asia Pacific Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)      
      2. By Indication 
        1. Asia Pacific Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)
      3. By Country     
        1. China 
          1. By Drug          
            1. China Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    
          2. By Indication 
            1. China Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)       
        2. Japan 
          1. By Drug          
            1. Japan Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    
          2. By Indication 
            1. Japan Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)       
        3. India  
          1. By Drug          
            1. India Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    
          2. By Indication 
            1. India Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)       
        4. Australia        
          1. By Drug          
            1. Australia Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)    
          2. By Indication 
            1. Australia Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)                               
        5. Rest of APAC
          1. By Drug          
            1. Rest of APAC Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)       
          2. By Indication 
            1. Rest of APAC Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)
  5. Middle East & Africa           
    1. By Drug          
      1. Middle East & Africa Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)     
    2. By Indication 
      1. Middle East & Africa Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)        
    3. By Country     
      1. Saudi Arabia 
        1. By Drug          
          1. Saudi Arabia Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)   
        2. By Indication 
          1. Saudi Arabia Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)     
      2. UAE    
        1. By Drug          
          1. UAE Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. UAE Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million) 
  6. Central & South America   
    1. By Drug          
      1. Central & South America Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million)        
    2. By Indication 
      1. Central & South America Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)         
    3. By Country     
      1. Brazil 
        1. By Drug          
          1. Brazil Neuroprotective Agents Market, By Drug, 2020-2026 (USD Million) 
        2. By Indication 
          1. Brazil Neuroprotective Agents Market, By Indication, 2020-2026 (USD Million)   

The global Neuroprotective Agents Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

Neuroprotective Agents Market

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Neuroprotective Agents Market.

Neuroprotective Agents Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Neuroprotective Agents Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Neuroprotective Agents Market

To request a free sample copy of this report, please complete the form below

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy
Request A Free Sample Report
Request For Customization

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation